Essential Hypertension, Heart Disease Risk Factors, Metabolic Cardiovascular Syndrome
Conditions
Keywords
Remote telemonitoring, Uncontrolled hypertension, Artificial intelligent
Brief summary
The purpose of this study is to evaluate the effectiveness of the use of artificial intelligence in home monitoring in patients with uncontrolled arterial hypertension.
Detailed description
Arterial hypertension (AH) is one of the most important cardiovascular risk factors, accounting for 13.5% of all deaths worldwide. Mobile health technologies have been applied as an important tool to improve patient engagement and blood pressure (BP) control, as an alternative approach to remote monitoring of hypertensive patients. Therefore, it is essential to help patients adopt healthy measures to assist in the daily control of BP. As the barriers to therapeutic adherence are complex and varied, solutions to improve adherence at the population level should be multifactorial. Therefore, the use of an application elaborated by artificial intelligence adapted to individual needs and customs, can help in improving therapeutic adherence and provide better bp control in patients with uncontrolled hypertension.
Interventions
DEVICEUsing the Avatr App
The patients will use the mobile application called Avatr, which will monitor their health data, as well as provide individualized care and early intervention through alerts generated for the multidisciplinary team.
Sponsors
InCor Heart Institute
University of Sao Paulo General Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
20 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
1. Primary arterial hypertension in drug treatment with at least 3 classes of antihypertensive drugs in optimized dose 2. Aged between 20 and 65 years 3. Blood pressure of the office ≥ 140 and/or 90 mmHg 4. Facilities to use mobile and apps
Exclusion criteria
1. Stroke sequelae 2. Cognitive dysfunction
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Blood pressure control | One year | Using the Avatr application with daily medication reminders, the patient will remember to use them. This way, there will be better control of blood pressure at home. Initially, 24-hour Ambulatory Blood Pressure Monitoring (ABPM) will be performed using the Spacelabs® device for initial control and during the four-monthly consultations, the mean blood pressure will be evaluated from the determination of systolic (SBP) and diastolic (DBP ) ) measured by an automatic sphygmomanometer (Omron HBP 1100 ®), on the right upper limb, with the individual sitting down, after 10 minutes of rest. |
| Glycemic control | One year | Diabetic patients will have a personalized dietary guidance and will measure their blood glucose daily with the glucometer, in order to control the baseline blood glucose value. |
| Change of out-of-hospital visits | One year | Change of extra-hospital visits during the monitoring period |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Patient engagement in treatment | One year | To assess patient engagement, a structured questionnaire will be applied to verify the usability of the AVATR, as well as to obtain knowledge about how patients felt when using the application and the impact of this monitoring on their health. |
| Improvement in lifestyle | One year | When performing daily physical activity after specialized evaluation and exercise prescription, with resistance and/or cardiovascular exercises, in addition to adhering to an adequate diet according to dietary guidelines, we can infer a reduction in weight (kg) and abdominal circumference (measurements in centimeter). |
Countries
Brazil
Outcome results
None listed